c-fos antisense oligodeoxynucleotide increases formalin-induced nociception and regulates preprodynorphin expression

Neuroscience. 1995 Mar;65(2):485-92. doi: 10.1016/0306-4522(94)00500-5.

Abstract

Rats, receiving an intrathecal pretreatment of oligodeoxynucleotide complementary to c-fos mRNA (antisense), showed no increases in Fos protein or preprodynorphin messenger RNA in the outer laminae of the lumbar spinal cord when challenged 4 h later with a 50 microliters intraplantar injection of 5% formalin. Animals pretreated with saline or sense oligodeoxynucleotide showed marked increases in Fos protein (2 h after formalin challenge) and preprodynorphin mRNA (20 h after formalin challenge) in the lumbar region of the cord ipsilateral to the side of the injection. The behavioural consequences of antisense pretreatment were an increase in the formalin-induced licking/biting responses during the tonic, but not the acute phase. These observations could be interpreted as representing a sequence of events beginning with the formalin-induced increase in the transcription factor Fos, which in turn increases the synthesis of preprodynorphin messenger RNA resulting in the production of the dynorphin opioid peptides which then exert a modulatory antinociceptive action.

MeSH terms

  • Animals
  • Base Sequence
  • Blotting, Northern
  • Cholecystokinin / biosynthesis
  • Dynorphins / biosynthesis*
  • Formaldehyde
  • Immunohistochemistry
  • In Situ Hybridization
  • Male
  • Molecular Sequence Data
  • Oligonucleotides, Antisense / pharmacology*
  • Pain Measurement / drug effects*
  • Protein Precursors / biosynthesis*
  • Proto-Oncogene Proteins c-fos*
  • RNA, Messenger / biosynthesis
  • Rats
  • Rats, Wistar

Substances

  • Oligonucleotides, Antisense
  • Protein Precursors
  • Proto-Oncogene Proteins c-fos
  • RNA, Messenger
  • pre-prodynorphin
  • Formaldehyde
  • Dynorphins
  • preprocholecystokinin
  • Cholecystokinin